Changes in the cytoplasmic (lactate dehydrogenase) and plasma membrane (acetylcholinesterase) marker enzymes in the synaptic and nonsynaptic mitochondria derived from rats with moderate hyperammonemia
- PMID: 8507304
- DOI: 10.1007/BF03160118
Changes in the cytoplasmic (lactate dehydrogenase) and plasma membrane (acetylcholinesterase) marker enzymes in the synaptic and nonsynaptic mitochondria derived from rats with moderate hyperammonemia
Abstract
The activities of the cytoplasmic and plasma membrane marker enzymes: lactate dehydrogenase (LDH) and acetylcholinesterase (AChE), respectively, were measured in the cerebral homogenates, in the synaptic and nonsynaptic mitochondrial fractions, and in the postmitochondrial supernatants derived from rats in which a 3-d, moderately hyperammonemic condition (no more than 120% increases in blood ammonia) was produced by repeated administration of ammonium acetate (simple hyperammonemia, SHA) or a hepatotoxin, thioacetamide (TAA) (hepatic encephalopathy, HE). As measured in the homogenate and postmitochondrial supernatants, neither of the enzyme activities was affected by SHA or HE. SHA and HE increased the synaptic mitochondrial LDH activity by respectively 53 and 24%, but reduced this enzyme activity in nonsynaptic mitochondria by 19%. Both conditions stimulated the synaptic and nonsynaptic mitochondrial AChE activity by 30-40%. By contrast, the only significant change produced in these fractions by in vitro treatment with a toxic (3 mM) concentration of ammonium chloride was a slight decrease of LDH activity in nonsynaptic mitochondria and postmitochondrial supernatants. It is concluded that moderate hyperammonemia modifies subsequent separation of both cerebral classes of mitochondria from the cytosolic and plasma membrane components. This modification is likely to reflect subtle hyperammonemia-related changes in the physicochemical properties of the two mitochondrial classes and/or other subcellular components.
Similar articles
-
Aspartate aminotransferase, malate dehydrogenase, and pyruvate carboxylase activities in rat cerebral synaptic and nonsynaptic mitochondria: effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy.Metab Brain Dis. 1991 Dec;6(4):187-97. doi: 10.1007/BF00996918. Metab Brain Dis. 1991. PMID: 1812392
-
The two catalytic components of the 2-oxoglutarate dehydrogenase complex in rat cerebral synaptic and nonsynaptic mitochondria: comparison of the response to in vitro treatment with ammonia, hyperammonemia, and hepatic encephalopathy.Neurochem Res. 1993 Feb;18(2):119-23. doi: 10.1007/BF01474673. Neurochem Res. 1993. PMID: 8474555
-
Hyperammonemia and hepatic encephalopathy stimulate rat cerebral synaptic mitochondrial glutamate dehydrogenase activity specifically in the direction of glutamate oxidation.Brain Res. 1993 Aug 6;618(2):299-302. doi: 10.1016/0006-8993(93)91279-2. Brain Res. 1993. PMID: 8104085
-
Effects of acute hyperammonemia in vivo on oxidative metabolism in nonsynaptic rat brain mitochondria.Metab Brain Dis. 1997 Mar;12(1):69-82. doi: 10.1007/BF02676355. Metab Brain Dis. 1997. PMID: 9101539
-
Rat cerebral mitochondrial glutaminase activity is unaffected by moderate hyperammonemia in two models.Acta Neurobiol Exp (Wars). 1996;56(2):545-8. doi: 10.55782/ane-1996-1158. Acta Neurobiol Exp (Wars). 1996. PMID: 8768304
Cited by
-
Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies.Anal Chem. 2018 Oct 16;90(20):11873-11882. doi: 10.1021/acs.analchem.8b01913. Epub 2018 Sep 28. Anal Chem. 2018. PMID: 30204418 Free PMC article.
-
Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy.Metab Brain Dis. 1994 Dec;9(4):401-7. doi: 10.1007/BF02098886. Metab Brain Dis. 1994. PMID: 7898405
-
Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg (2+)-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia.Metab Brain Dis. 2008 Sep;23(3):255-64. doi: 10.1007/s11011-008-9091-8. Epub 2008 Jul 30. Metab Brain Dis. 2008. PMID: 18665440
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials